BioMatrix Alpha Drug-Eluting Stent

Biodegradable Polymer Coated Cobalt-Chromium Stent delivering Biolimus A9™ for restenosis prevention.

Description

The BioMatrix Alpha is a next-generation drug-eluting stent system featuring a cobalt-chromium platform and biodegradable polymer. It delivers Biolimus A9™ to prevent restenosis while minimizing long-term polymer exposure, offering exceptional safety and performance.

Key Features

Biodegradable Coating: Fully absorbed in 6–9 months for localized, temporary drug delivery.
BA9™ Drug: Sustained release of Biolimus A9™ for effective restenosis prevention.
Cobalt-Chromium Platform: Combines radial strength, flexibility, and optimal deliverability.